Tradestie Institutional Equity Comparison Engine

AXNX vs SIBN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SIBN Overall Edge

SIBN Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SI-BONE, Inc. Common Stock (SIBN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SIBN at N/M Forward P/E and -7.6% operating margin (+14.5% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SIBN sits in BREAKOUT (48th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AXNX N/M vs SIBN N/M Fwd P/E
Growth & Margin Winner SIBN
Op Margin N/A vs -7.6% ยท YoY N/A vs +14.5%
Momentum & Technical Winner SIBN
1Y +16.9% vs +27.6% ยท 52W Pos 50% vs 85%
Options & Structure Winner SIBN
UNCLASSIFIED (N/A IV) vs BREAKOUT (48th %ile IV)
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
SIBN NASDAQ
SI-BONE, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$23.73
-0.08% 1D
Market Cap $1.1B
1M Return +10.06%
1Y Return +27.58%
Forward P/E N/M
Unified AI Score
53.5 / 100 HOLD
Tech 45.0 Fund 57.0 Flow 72.0 Mom 56.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AXNX +16.92% SIBN +27.58% Spread: +3.66 pp (SIBN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AXNX TTM Op. Margin: N/A SIBN TTM Op. Margin: -7.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs SIBN. Trailing 12-month operating profitability (AXNX N/A vs SIBN -7.6%) and valuation multiples (AXNX N/M vs SIBN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AXNX (0) vs SIBN (8)
Institutional Metric AXNX SIBN Criterion Row Winner
Market Capitalization Scale N/A $1.1B Larger Scale SIBN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +14.5% Higher Growth SIBN
Operating Margin (TTM) Profitability N/A -7.6% Higher Margin SIBN
Net Profit Margin Profitability N/A -6.2% Higher Margin SIBN
Return on Equity (ROE) Capital Efficiency N/A -7.7% Higher ROE SIBN
52-Week Range Position Momentum 50% ($0โ€“$1) 85% ($11โ€“$26) Stronger Trend SIBN
Beta / 30D Volatility Risk Regime N/A 0.65ฮฒ ยท 74% Vol Lower Realized Risk SIBN
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 53.5 / 100 (HOLD) Higher Composite SIBN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AXNX vs SIBN Buy Guide
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SIBN BREAKOUT
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 48th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SIBN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AXNX nor SIBN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.